These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibacterial drug discovery and development--SRI's 11th Annual Summit. Antibacterial trends and current research. Silver LL IDrugs; 2006 Jun; 9(6):394-7. PubMed ID: 16752305 [No Abstract] [Full Text] [Related]
3. Late stage antibacterial drugs in the clinical pipeline. Projan SJ; Bradford PA Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658 [TBL] [Abstract][Full Text] [Related]
4. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges. Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498 [TBL] [Abstract][Full Text] [Related]
5. Stepping up to the plate. Nat Immunol; 2008 Jan; 9(1):1. PubMed ID: 18087245 [No Abstract] [Full Text] [Related]
6. Antibacterial drug discovery in the 21st century. Bush K Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():10-7. PubMed ID: 15522035 [TBL] [Abstract][Full Text] [Related]
19. How beta-lactamases have driven pharmaceutical drug discovery. From mechanistic knowledge to clinical circumvention. Bush K; Mobashery S Adv Exp Med Biol; 1998; 456():71-98. PubMed ID: 10549364 [No Abstract] [Full Text] [Related]
20. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective. Chopra I; Hodgson J; Metcalf B; Poste G JAMA; 1996 Feb; 275(5):401-3. PubMed ID: 8569021 [No Abstract] [Full Text] [Related] [Next] [New Search]